Integrated Filing (Financial) for the Quarter and Nine months ended on 31st December, 2025
VCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaxtex Cotfab Limited has submitted its Integrated Financial Filing for the third quarter (Q3 FY26) and the nine-month period ended December 31, 2025, on the NSE. This is a standard SEBI-prescribed quarterly filing that typically combines the financial results (revenue, expenses, profit/loss), balance sheet, cash flow statement, and key regulatory disclosures into a single document. The headline alone does not disclose the actual numbers, auditor remarks, or any specific ratio. Investors need to open the full filing to view the income statement, segment data, and any notes from management or auditors.
This is a routine compliance filing rather than a market-moving event on its own. The real impact on the stock will depend on the actual revenue, profit/loss numbers, margins, and any auditor qualifications or emphasis-of-matter paragraphs inside the full document.